Approves a New Pill to Slash Cholesterol Levels The New York Times * FDA Approves First-of-Its-Kind Cholesterol Pill, Ushering In New Wave of Treatment WSJ * Drugmaker Merck announces approval of new cholesterol-fighting drug The Guardian * Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment Fierce Pharma #Merck #Cholesterol #FDAApproval #Lipfendra #HealthInnovation To view or add a comment, sign in FDA has approved the first-ever oral PCSK9 drug for milliions battling high cholesterol
The most cited single result is from Yun and colleagues in 2018, who showed that NLY01, a long-acting PEGylated GLP-1R agonist, blocked the microglia-driven conversion of resting astrocytes into the neurotoxic A1 phenotype in mouse models, a process implicated in neuronal death in both Parkinsons and Alzheimers disease [4]
Virushost interactome Virus-human host proteinprotein interactions play a major role in clinical outcomes of acute SARS-CoV-2 infection and its long-term sequelae, the PASC
But confidence in technique only takes you so far when the real challenge is maintaining that consistency week after week without slipping
Figures 1 and 2 show an example of a woman who developed infected knots on both arms one week after receiving unapproved fat-dissolving injections
Gutbrain signaling research: Exploring how amylin-related signaling contributes to appetite and satiety pathways in brain regions involved in hunger regulation
